2024-10-22 20:34:06
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer
Corporate/ 2023-07-24
Transcenta Announces Global Clinical Col...

SUZHOU,China,March 22,2022-- Transcenta Holding Limited ("Transcenta") (HKEX: 06628),a clinical stage biopharmaceutical company wi...

Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma
Corporate/ 2023-07-24
Ascentage Pharma's MDM2-p53 Inhibit...

SUZHOU,China,and ROCKVILLE,MD,March 22,2022-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel ther...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release